Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 ...

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.

The findings, published in The Lancet Respiratory Medicine, suggest that dupilumab, when used alongside standard triple ...

Explore Regeneron's Q1 2025 earnings with updates on Dupixent growth, EYLEA challenges, FDA hurdles, and upcoming approvals.

Chronic Obstructive Pulmonary Disease (COPD) Market. COPD market grows with rising disease prevalence, innovation in therapies, and increasing global healt ...

Nottinghamshire Healthcare’s community respiratory nurses are excited to pilot a brand new programme for patients with newly ...

Discover how new cryptocurrency releases are sparking excitement in the market. Capitalize on the frenzy with this insightful ...

Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

A new study published in the journal of BMC Pulmonary Medicine showed that dyspnea (mMRC score 1.67), symptom load (CAT score ...

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

"I wanted to create an improved fan filter to capture small dust particles, allergens, and debris while the fan was rotating," said an inventor, from Lansing, Ill., "so I invented the FAN FILTER. My ...

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.